10:31 EST Corcept Therapeutics (CORT) trading resumes
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORT:
- Corcept Therapeutics trading halted, volatility trading pause
- Is CORT a Buy, Before Earnings?
- Corcept TherapeuticCRL does not change investment thesis, says Canaccord
- Corcept falls as FDA reveals it warned of CRL rejection for relacorilant
- Corcept Therapeutics call volume above normal and directionally bullish